Cognitive impairment in diabetes mellitus and hypertension, a possibility of correction
Objective: to evaluate cognitive functions in patients with type 2 diabetes mellitus (DM2) and hypertension and the efficacy of Ginkgo biloba extract Egb 761®.Patients and methods. 120 patients with DM2 and 50 hypertensive patients with no complications or a history of stroke and/or myocardial infar...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2016-11-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/646 |
| _version_ | 1827062837343682560 |
|---|---|
| author | I. Ch. Khairullin R. G. Esin O. R. Esin |
| author_facet | I. Ch. Khairullin R. G. Esin O. R. Esin |
| author_sort | I. Ch. Khairullin |
| collection | DOAJ |
| description | Objective: to evaluate cognitive functions in patients with type 2 diabetes mellitus (DM2) and hypertension and the efficacy of Ginkgo biloba extract Egb 761®.Patients and methods. 120 patients with DM2 and 50 hypertensive patients with no complications or a history of stroke and/or myocardial infarction, without active complaints of hypomnesia and other cognitive functions were examined. The exclusion criteria were prior stroke and/or myocardial infarction; clinically significant diseases of the peripheral arteries and major arteries of the head; DM2 decompensation; glomerular filtration rate <60 ml/min; proliferative retinopathy; and other endocrine diseases. The investigators used the following methods for the evaluation of cognitive functions: the Mini-Mental State Examination, the Montreal Cognitive Assessment, and the hand- eye coordination test (Parts A and B).Results and discussion. 85% of the patients with DM2 were found to have cognitive impairments (CI): disorders of attention, short-term memory, and thinking speed. Out of them, 82.5% had moderate CI and 2.5% had dementia. 30% of the hypertensive patients were diagnosed as having moderate CIs and 10% had dementia. At the same time, the degree of CI was higher in the patients with MD2 than in those with hypertension. The use of Egb 761® 240 mg/day for 3 months had a statistically significant positive impact on cognitive functions (improvements in short-term memory, concentration, and thinking speed) and everyday activity.Conclusion. The authors consider that CIs are the first sign of encephalopathy in DM2. It is also noted that DM2 has a more pronounced impact on cognitive functions than hypertension. Egb 761® can be used as an effective drug to treat CI in these diseases. |
| first_indexed | 2024-04-10T02:02:57Z |
| format | Article |
| id | doaj.art-53cf8312c81d4899ae98377876d36b46 |
| institution | Directory Open Access Journal |
| issn | 2074-2711 2310-1342 |
| language | Russian |
| last_indexed | 2025-02-18T20:03:12Z |
| publishDate | 2016-11-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Неврология, нейропсихиатрия, психосоматика |
| spelling | doaj.art-53cf8312c81d4899ae98377876d36b462024-10-17T16:15:23ZrusIMA-PRESS LLCНеврология, нейропсихиатрия, психосоматика2074-27112310-13422016-11-0183485210.14412/2074-2711-2016-3-48-52585Cognitive impairment in diabetes mellitus and hypertension, a possibility of correctionI. Ch. Khairullin0R. G. Esin1O. R. Esin2Kazan (Volga) Federal University. Kazan, Russia 18, Kremlevskaya St., Kazan 420008, Republic of TatarstanKazan (Volga) Federal University. Kazan, Russia 18, Kremlevskaya St., Kazan 420008, Republic of Tatarstan Kazan State Medical University, Ministry of Health of Russia, Kazan, Russia 49, Butlerov St., Kazan 420012, Republic of TatarstanKazan (Volga) Federal University. Kazan, Russia 18, Kremlevskaya St., Kazan 420008, Republic of TatarstanObjective: to evaluate cognitive functions in patients with type 2 diabetes mellitus (DM2) and hypertension and the efficacy of Ginkgo biloba extract Egb 761®.Patients and methods. 120 patients with DM2 and 50 hypertensive patients with no complications or a history of stroke and/or myocardial infarction, without active complaints of hypomnesia and other cognitive functions were examined. The exclusion criteria were prior stroke and/or myocardial infarction; clinically significant diseases of the peripheral arteries and major arteries of the head; DM2 decompensation; glomerular filtration rate <60 ml/min; proliferative retinopathy; and other endocrine diseases. The investigators used the following methods for the evaluation of cognitive functions: the Mini-Mental State Examination, the Montreal Cognitive Assessment, and the hand- eye coordination test (Parts A and B).Results and discussion. 85% of the patients with DM2 were found to have cognitive impairments (CI): disorders of attention, short-term memory, and thinking speed. Out of them, 82.5% had moderate CI and 2.5% had dementia. 30% of the hypertensive patients were diagnosed as having moderate CIs and 10% had dementia. At the same time, the degree of CI was higher in the patients with MD2 than in those with hypertension. The use of Egb 761® 240 mg/day for 3 months had a statistically significant positive impact on cognitive functions (improvements in short-term memory, concentration, and thinking speed) and everyday activity.Conclusion. The authors consider that CIs are the first sign of encephalopathy in DM2. It is also noted that DM2 has a more pronounced impact on cognitive functions than hypertension. Egb 761® can be used as an effective drug to treat CI in these diseases.https://nnp.ima-press.net/nnp/article/view/646diabetes mellitus type 2diabetic encephalopathycognitive impairmentcognitive functionshypertensionegb 761®. |
| spellingShingle | I. Ch. Khairullin R. G. Esin O. R. Esin Cognitive impairment in diabetes mellitus and hypertension, a possibility of correction Неврология, нейропсихиатрия, психосоматика diabetes mellitus type 2 diabetic encephalopathy cognitive impairment cognitive functions hypertension egb 761®. |
| title | Cognitive impairment in diabetes mellitus and hypertension, a possibility of correction |
| title_full | Cognitive impairment in diabetes mellitus and hypertension, a possibility of correction |
| title_fullStr | Cognitive impairment in diabetes mellitus and hypertension, a possibility of correction |
| title_full_unstemmed | Cognitive impairment in diabetes mellitus and hypertension, a possibility of correction |
| title_short | Cognitive impairment in diabetes mellitus and hypertension, a possibility of correction |
| title_sort | cognitive impairment in diabetes mellitus and hypertension a possibility of correction |
| topic | diabetes mellitus type 2 diabetic encephalopathy cognitive impairment cognitive functions hypertension egb 761®. |
| url | https://nnp.ima-press.net/nnp/article/view/646 |
| work_keys_str_mv | AT ichkhairullin cognitiveimpairmentindiabetesmellitusandhypertensionapossibilityofcorrection AT rgesin cognitiveimpairmentindiabetesmellitusandhypertensionapossibilityofcorrection AT oresin cognitiveimpairmentindiabetesmellitusandhypertensionapossibilityofcorrection |